Home/Filings/4/0001578563-25-000029
4//SEC Filing

VARKI PAUL 4

Accession 0001578563-25-000029

CIK 0001534120other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 5:51 PM ET

Size

5.6 KB

Accession

0001578563-25-000029

Insider Transaction Report

Form 4
Period: 2025-01-28
VARKI PAUL
Chief Legal Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-01-28+100,000100,000 total
    Exercise: $8.04Exp: 2035-01-28Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The stock option vests twenty-five percent (25%) on January 28, 2026 and the remainder will vest in equal monthly installments over the following three (3) years, subject to the Reporting Person's continued service on such vesting date.

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1
  • filerCIK 0001677896

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 5:51 PM ET
Size
5.6 KB